Verdence Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4M | Sell |
|
|||||
|
2025
Q1 | $3.71M | Sell |
|
|||||
|
2024
Q4 | $3.78M | Sell |
|
|||||
|
2024
Q3 | $4.08M | Buy |
|
|||||
|
2024
Q2 | $3.07M | Buy |
|
|||||
|
2024
Q1 | $3.32M | Buy |
|
|||||
|
2023
Q4 | $2.19M | Buy |
|
|||||
|
2023
Q3 | $2.39M | Sell |
|
|||||
|
2023
Q2 | $3.08M | Buy |
|
|||||
|
2023
Q1 | $3.33M | Sell |
|
|||||
|
2022
Q4 | $3.49M | Sell |
|
|||||
|
2022
Q3 | $3.69M | Sell |
|
|||||
|
2022
Q2 | $4.46M | Sell |
|
|||||
|
2022
Q1 | $5.02M | Sell |
|
|||||
|
2021
Q4 | $7.1M | Buy |
|
|||||
|
2021
Q3 | $6.38M | Buy |
|
|||||
|
2021
Q2 | $6.27M | Buy |
|
|||||
|
2021
Q1 | $4.38M | Sell |
|
|||||
|
2020
Q4 | $4.33M | Buy |
|
|||||
|
2020
Q3 | $4.16M | Buy |
|
|||||
|
2020
Q2 | $976K | Buy |
|
|||||
|
2020
Q1 | $660K | Sell |
|
|||||
|
2019
Q4 | $766K | Buy |
|
|||||
|
2019
Q3 | $510K | Buy |
|
|||||
|
2019
Q2 | $402K | Buy |
|
|||||
|
2019
Q1 | $417K | Buy |
|
|||||
|
2018
Q4 | $448K | Buy |
|
|||||
|
2018
Q3 | $532K | Sell |
|
|||||
|
2018
Q2 | $539K | Sell |
|
|||||
|
2018
Q1 | $683K | Sell |
|
|||||
|
2017
Q4 | $748K | Buy |
|